Clinical trial

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

NCT02130687

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sitagliptin Normalized identity: sitagliptinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Aprepitant Normalized identity: aprepitantView linked drug · Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Mixed Meal Test (MMT) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-06-01

PhaseNA

Conditions

Type 2 Diabetes Mellitusverified · MONDO: type 2 diabetes mellitus

Hypertensionunresolved

Interventions

PlaceboDRUG

SitagliptinDRUG · verified · RxNorm: sitagliptin

AprepitantDRUG · verified · RxNorm: aprepitant

Mixed Meal Test (MMT)OTHER

Sponsors & collaborators

Vanderbilt Universitylead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02130687 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.